Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial
Provided By GlobeNewswire
Last update: Sep 9, 2025
European expansion in September across Georgia, Italy, Lithuania, Poland, Romania, Spain, and US
13 subjects recruited (treated, enrolled, or screened)
Read more at globenewswire.com
